Silanes is a responsible company committed to patient safety and well-being. This is why the Pharmacovigilance Unit contact details are made available. This unit is responsible for monitoring Silanes and Instituto Bioclon-manufactured and/or marketed drug use.
Pharmacovigilance is defined by the World Health Organization as science and activities aimed at detecting, assessing, understanding, and preventing drug adverse effects or other related problems.
If you suspect that you, a relative, or a friend shows any adverse effects while on a Silanes medication, we will ask you to contact us through the following:
Likewise, we request that you inform us if you occupied or consumed any of our products in any of the following situations:
-Exposure during pregnancy or lactation
-Overdose
-Misuse or medication error
-Suspicion of transmission of an infectious agent through a product,
-Lack of effectiveness.
-Occupational exposure to the product.
-Use out of indication
-Counterfeit medication
-Drug-drug-food interaction
-Beneficial effect
In order to report the adverse event that has occurred, it is important to consider that we require at least the following:
1.Datos del paciente: Iniciales, fecha de nacimiento, sexo, edad.
2.Producto (s) implicado (s) de Silanes o Bioclon: Nombre del producto, dosis, via de administración, número de lote y fecha de caducidad.
3.Evento adverso o problema presentado: Descripción de los signos, síntomas o situación que presenta o presentó.
4.Datos del informante: Nombre de la persona que proporciona la informacion y datos de contacto (número telefónico, correo electrónico, etc.)
Please enter the information in our form
We ask that you please provide the most information obtained, even if you do not have all the data listed above.
In accordance with the provisions of the Federal Law on Protection of Personal Data Held by Private Parties, LABORATORIOS SILANES, S.A. OF C.V. puts at your disposal the following Privacy Notice for Pharmacovigilance.